Based on these findings, it is reasonable to speculate that tumours with more intrinsic genomic alterations, especially with driver events such as RB1/TP53 alterations, are more likely to evolve towards an NE phenotype even in the absence of therapeutic stress. This evidence concerns the gene TP53 and neoplasm.